机器人对比腹腔镜与开腹远端胃切除术治疗局部晚期胃癌:基于前瞻性试验的经济学评价
该研究基于两项随机对照试验的449例局部晚期胃癌患者,采用逆概率治疗加权和决策分析模型,比较机器人、腹腔镜与开腹远端胃切除术的成本效果。机器人手术短期结局和生活质量更优,但增量成本效果比显著超过中国人均GDP三倍阈值,经济负担需在临床决策中考虑。
要点
- 机器人远端胃切除术短期结局和生活质量优于腹腔镜与开腹手术。
- 机器人对比腹腔镜的ICER为每QALY 85,739.73美元,超过中国支付意愿阈值。
- 机器人手术的间接成本是影响其成本效果的最重要因素之一。
核心结论
- 机器人远端胃切除术虽改善短期结局和生活质量,但经济负担需在局部晚期胃癌临床决策中考虑。
研究设计与样本
- 基于两项随机对照试验(CLASS-01和FUGES-011)的汇总分析,共纳入449例局部晚期胃癌患者。
- 采用逆概率治疗加权平衡基线特征,并构建决策分析模型评价成本效果。
主要发现
- 逆概率加权后,机器人组在失血量、术后住院时间和并发症率方面均优于腹腔镜和开腹组(均P < 0.05)。
- 机器人组生活质量更高但成本更高,对比腹腔镜的ICER为每QALY 85,739.73美元,对比开腹为每QALY 42,189.53美元。
- 概率敏感性分析中,仅当支付意愿阈值超过每QALY 85,739.73美元时机器人手术才最具成本效果,该阈值显著超过中国人均GDP三倍。
临床怎么用
- 在局部晚期胃癌中选择机器人远端胃切除术时,需结合支付意愿阈值和间接成本评估其经济可行性。
局限性
- 研究结果可能因不同医疗环境和支付能力而有所差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: It is largely unclear whether robotic distal gastrectomy (RDG) is cost-effective for locally advanced gastric cancer (LAGC). OBJECTIVE: To evaluate the cost-effectiveness of RDG, laparoscopic distal gastrectomy (LDG), and open distal gastrectomy (ODG) for patients with LAGC. DESIGN, SETTING, AND PARTICIPANTS: Inverse probability of treatment weighting (IPTW) was used to balance baseline characteristics. A decision-analytic model was constructed to evaluate the cost-effectiveness of RDG, LDG, and ODG. EXPOSURES: RDG, LDG, and ODG. MAIN OUTCOMES AND MEASURES: Incremental cost-effectiveness ratio (ICER) and quality-adjusted life year (QALY). RESULTS: This pooled analysis of two randomized controlled trials included 449 patients: 117, 254, and 78 patients in the RDG, LDG, and ODG groups, respectively. After IPTW, RDG demonstrated its priority in terms of less blood loss, postoperative length, and complication rate (all P < 0.05). RDG also showed higher QOL with more cost, representing an ICER of $85,739.73 per QALY and $42,189.53 per QALY compared to LDG and ODG, respectively. In probabilistic sensitivity analysis, RDG achieved the best cost-effectiveness for patients with LAGC only when the willingness-to-pay threshold was > $85,739.73 per QALY, which significantly exceeded 3 times Chinese per capita GDP. Furthermore, one of the most important factors was the indirect costs of robotic surgery in terms of the cost-effectiveness of RDG compared to that of LDG or ODG. CONCLUSIONS AND RELEVANCE: Although improved short-term outcomes and QOL were seen in patients underwent RDG, the economic burden should be considered in the clinical decision-making regarding robotic surgery use for patients with LAGC. Our findings may vary in different health care settings and affordability. Trial registration CLASS-01 trial (ClinicalTrials.gov, CT01609309) and FUGES-011 trial (ClinicalTrials.gov, NCT03313700).
引用
- Lu J, Wu D, Huang JB, et al. Comparison of robotic versus laparoscopic versus open distal gastrectomy for locally advanced gastric cancer: a prospective trial-based economic evaluation. Surg Endosc. 2023. PMID: 37395806. doi:10.1007/s00464-023-10147-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。